Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons

BACKGROUND: This literature review assessed comparative efficacy and safety of long-acting muscarinic antagonist/long-acting β(2)-agonist (LAMA/LABA) fixed-dose combinations (FDCs) in patients with COPD and moderate-to-very severe airflow limitation, using evidence from direct (head-to-head) and ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurst, John R, Gruffydd-Jones, Kevin, Biswas, Mousumi, Guranlioglu, Deniz, Jenkins, Martin, Stjepanovic, Neda, Bamrara, Arushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336124/
https://www.ncbi.nlm.nih.gov/pubmed/32669839
http://dx.doi.org/10.2147/COPD.S230955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336124/
https://www.ncbi.nlm.nih.gov/pubmed/32669839
http://dx.doi.org/10.2147/COPD.S230955

Ejemplares similares